Patient's perception of exacerbations of COPD - the PERCEIVE study

被引:92
|
作者
Miravitlles, Marc [1 ]
Anzueto, Antonio
Legnani, Delfino
Forstmeier, Leonhard
Fargel, Matthias
机构
[1] Hosp Clin Barcelona, Inst Clin Torax IDIBAPS, Serv Pneumol, Barcelona, Spain
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78285 USA
[3] S Texas Vet Hlth Care Syst, San Antonio, TX USA
[4] Univ Milan, Inst Resp Dis, Milan, Italy
[5] Bayer HealthCare, Wuppertal, Germany
[6] Psyma Int Med Mkt Res GmbH, Rueckersdorf Nuernberg, Germany
关键词
COPD; chronic bronchitis; patient-reported outcomes; respiratory symptoms;
D O I
10.1016/j.rmed.2006.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The evaluation of therapies requires the development of patient-reported outcomes (PROs) that help clinicians to understanding the symptoms, perceptions and feelings of patients with exacerbations of chronic obstructive pulmonary disease (COPD). With the aim of obtaining information on the perceptions of patients with COPD, their exacerbations and expectations of treatment, a random telephone contact survey in six countries was performed. From 83,592 households screened, 1100 subjects with symptoms compatible with COPD were identified. The most frequent symptom was shortness of breath (78%). The most frequent complaint was that due to their COPD: "they could not complete the activities they like to do" (54%); 17% (187) of individuals were afraid that their COPD would cripple, or eventually kill them. Exacerbations generated a mean of 5.1 medical visits/year (SD=4.6) with the mean duration of exacerbation symptoms being 10.5 days. Increased coughing was the exacerbation symptom having the strongest impact on well-being (42%). Fifty-five percent of patients declared that quicker symptom relief was the most desired requirement for treatment. New data are provided on the impact of COPD and its exacerbations on the daily life of patients. These data will help to develop PROs designed to evaluate the effectiveness of different therapies for exacerbated COPD. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:453 / 460
页数:8
相关论文
共 50 条
  • [41] Costs of exacerbations in COPD
    Jansson, Sven-Arne
    Backman, Helena
    Ronmark, Eva
    Lundback, Bo
    Lindberg, Anne
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [42] Management of COPD Exacerbations
    Evensen, Ann E.
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (05) : 607 - 613
  • [43] COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study
    Miravitlles, Marc
    Izquierdo, Inaki
    Herrejon, Alberto
    Vicente Torres, Juan
    Baro, Eva
    Borja, Javier
    RESPIRATORY MEDICINE, 2011, 105 (05) : 740 - 747
  • [44] Mindfulness interventions in acute exacerbations of COPD - a feasibility study
    Tschenett, Hannah
    Vafai-Tabrizi, Florian
    Nater, Urs Markus
    Funk, Georg-Christian
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 616 - 616
  • [45] Costs of COPD exacerbations in Poland (results of the pilot study)
    Jahnz-Rozyk, K. M.
    Targowski, T.
    From, S.
    VALUE IN HEALTH, 2006, 9 (06) : A261 - A261
  • [46] Acute exacerbations of COPD
    Balzano, Gianni
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2009, 4 (01): : 70 - 71
  • [47] Impact of exacerbations on COPD
    Anzueto, A.
    EUROPEAN RESPIRATORY REVIEW, 2010, 19 (116): : 113 - 118
  • [48] COPD patients' experiences and understanding of exacerbations: a qualitative study
    Crooks, M.
    Russell, R.
    Cummings, H.
    Roy, K.
    Usmani, O.
    Cohen, J.
    Macfadyan, S.
    Morris, T.
    Mullerova, H.
    Xu, Y.
    Hutchinson, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [49] TREATMENT OF EXACERBATIONS OF COPD
    ROSEN, MJ
    AMERICAN FAMILY PHYSICIAN, 1992, 45 (02) : 693 - 697
  • [50] Antibiotics for COPD exacerbations
    Labaki, Wassim W.
    Han, MeiLan K.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (06): : 461 - 462